Welcome to our dedicated page for Globe Life SEC filings (Ticker: GL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Globe Life Inc. filings document operating results, governance and capital-structure disclosures for an insurance holding company focused on life and supplemental health insurance. Current reports include earnings releases furnished on Form 8-K, with disclosures on net income, net operating income, underwriting margins, premium revenue and guidance.
Proxy and governance filings cover director elections, shareholder voting results, advisory executive compensation matters, board composition, non-employee director compensation and executive retirement plan amendments. The filing record also identifies registered securities including common stock and subordinated debt, alongside recurring disclosures tied to shareholder meetings and corporate governance procedures.
GLOBE LIFE INC. executive vice president and CFO Thomas Peter Kalmbach reported a combination of option exercise and share sale involving the company’s common stock. He exercised employee stock options for 10,000 shares at an exercise price of $103.23 per share and converted them into common stock.
On the same date, he sold 7,936 common shares in an open-market transaction at an average price of $156.5914 per share, with actual sale prices ranging from $156.25 to $157.08 per share. Following these transactions, he holds 50,495.7065 common shares directly and 1,152.787 shares indirectly through a 401(k) plan.
GLOBE LIFE INC. Co-Chairman & CEO Frank M. Svoboda reported an option exercise and related stock sales of the company’s common stock. He exercised 20,000 shares through employee stock options at an exercise price of $100.74 per share and then sold 20,000 shares in open-market transactions at average prices of $156.65 and $157.05 per share.
Following these transactions, he directly holds 54,020.4648 shares of common stock. He also reports indirect holdings through a 401(k) plan, an irrevocable trust, a spouse’s irrevocable trust and a family trust, including 103,473 shares held in a family trust.
Globe Life Inc. filed a Form 144/A reporting a proposed sale of 35,000 shares of common stock related to a Stock Option Exercise. The filing lists secondary sales by Thomas Kalmbach: 11,790 shares sold on 05/08/2026 for $1,792,362.96 and 15,637 shares sold on 05/11/2026 for $2,402,640.68.
GLOBE LIFE INC. Executive Vice President and CFO Thomas Peter Kalmbach reported option exercises and share sales in company stock. On 2026-05-19, he exercised employee stock options for 15,000 shares of common stock at an exercise price of $103.23 per share and acquired those shares.
The same day, he completed an open-market sale of 11,903 shares of common stock at an average price of about $156.6148 per share, with sale prices ranging from $156.145 to $157.05 per share. After these transactions, he beneficially owned 48,431.7065 shares directly and 1,152.787 shares indirectly through a 401(k) plan, and held 20,000 remaining employee stock options at a $103.23 exercise price expiring on 2029-02-23.
Globe Life Inc. submitted a Rule 144 notice for the proposed sale of 20,000 shares of Common Stock on 05/19/2026, identified as arising from a Stock Option Exercise with proceeds described as “Proceeds of Stock Option Exercise.” The filing lists prior sales of 12,854 shares on 05/05/2026 for $1,974,421.95. The record also shows 77,957,478 shares outstanding as of 05/19/2026.
Globe Life Inc filed a notice disclosing a proposed sale of 35,000 shares of Common Stock pursuant to a stock option exercise on 05/19/2026. The filing lists prior sales in the past three months totaling 27,427 shares (11,790 and 15,637) with aggregate proceeds of $1,792,362.96 and $2,402,640.68 respectively.
The proposed transaction names Thomas Kalmbach and shows Apex Clearing as the broker-dealer. The filing records 77,957,478 shares outstanding with a reference value of $5,507,250 associated with the 35,000-share line item on 05/19/2026.
GLOBE LIFE INC. Executive Vice President and CFO Thomas Peter Kalmbach reported a mix of option exercises and share sales in company stock. On May 8 and May 11, 2026, he exercised employee stock options covering 35,000 shares of common stock at an exercise price of $98.32 per share.
Across those same dates, he executed open-market sales totaling 27,427 shares of common stock at prices generally in the $151–$154 range, as detailed in the price-range footnotes. Following these transactions, he holds 45,334.7065 shares of Globe Life common stock directly and an additional 1,151.516 shares indirectly through a 401(k) plan. His direct holdings figure also reflects 7.6337 dividend equivalent restricted stock units accumulated since the prior report.
Globe Life Inc. filed a Form 13F reporting institutional holdings. The report lists 2 holdings in the 13F information table with a reported aggregate market value of $380,804,548. The filing was signed by Christopher T. Moore on 05-11-2026.